FATE · Categories · Form 4

FATE - SEC Form 4 insider transactions

Fate Therapeutics Inc. (FATE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for FATE

• 20d
  Officer Tahl Cindy sold $95,405 worth of shares (38,800 units at $2.46), decreasing direct ownership by 6% to 589,355 units (SEC Form 4) to satisfy withholding obligation

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 20d
  President and CEO Valamehr Bahram sold $108,101 worth of shares (43,947 units at $2.46), decreasing direct ownership by 7% to 591,815 units (SEC Form 4) (tax withholding)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Lee Michael Stewart

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Xu Yuan

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Jooss Karin

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Epstein Robert S

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Agarwal Shefali

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Abernethy Matt

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Rastetter William H

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 71d
  SEC Form 4 filed by Director Hamill Laura

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 96d
  Officer Tahl Cindy sold $48,084 worth of shares (25,590 units at $1.88), decreasing direct ownership by 4% to 628,155 units (SEC Form 4) (withholding obligation)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 96d
  President and CEO Valamehr Bahram sold $54,482 worth of shares (28,946 units at $1.88), decreasing direct ownership by 4% to 635,762 units (SEC Form 4) to satisfy withholding tax

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 110d
  Officer Tahl Cindy exercised 166,664 shares at a strike of $1.25, increasing direct ownership by 34% to 653,745 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 111d
  Director Epstein Robert S exercised 25,000 shares at a strike of $1.69, increasing direct ownership by 221% to 36,331 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 111d
  Director Rastetter William H exercised 25,000 shares at a strike of $1.69, increasing direct ownership by 221% to 36,331 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 124d
  Amendment: SEC Form 4 filed by Director Redmile Group, Llc

  4/A - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 125d
  SEC Form 4 filed by Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 221d
  Officer Tahl Cindy was granted 100,000 shares, increasing direct ownership by 26% to 487,081 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 221d
  Chief Financial Officer Adawi Kamal was granted 25,000 shares, increasing direct ownership by 33% to 100,000 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 221d
  President and CEO Valamehr Bahram was granted 335,000 shares, increasing direct ownership by 102% to 664,708 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 225d
  Officer Tahl Cindy sold $11,275 worth of shares (10,589 units at $1.06), decreasing direct ownership by 3% to 387,081 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 225d
  President and CEO Valamehr Bahram sold $5,557 worth of shares (5,190 units at $1.07), decreasing direct ownership by 2% to 329,708 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 308d
  Chief Financial Officer Adawi Kamal was granted 75,000 shares (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 385d
  Officer Tahl Cindy sold $9,573 worth of shares (9,037 units at $1.06), decreasing direct ownership by 2% to 397,670 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 385d
  President and CEO Valamehr Bahram sold $15,396 worth of shares (14,466 units at $1.06), decreasing direct ownership by 4% to 334,898 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Lee Michael Stewart

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Xu Yuan

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Mozaffarian Neelufar

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Rastetter William H

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Mendlein John

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Jooss Karin

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Epstein Robert S

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Abernethy Matt

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 452d
  SEC Form 4 filed by Director Agarwal Shefali

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 586d
  SEC Form 4 filed by President and CEO Valamehr Bahram

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 586d
  Officer Tahl Cindy was granted 70,000 shares, increasing direct ownership by 21% to 406,707 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 586d
  Officer Bressi Jerome Charles was granted 65,000 shares, increasing direct ownership by 24% to 335,203 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 589d
  Officer Bressi Jerome Charles sold $9,269 worth of shares (5,980 units at $1.55), decreasing direct ownership by 2% to 270,203 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 589d
  Officer Tahl Cindy sold $8,764 worth of shares (5,654 units at $1.55), decreasing direct ownership by 2% to 336,707 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 589d
  President and CEO Valamehr Bahram sold $13,406 worth of shares (8,705 units at $1.54), decreasing direct ownership by 2% to 349,364 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 617d
  Director Redmile Group, Llc converted options into 30,110 shares (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 748d
  Director Xu Yuan sold $2,678 worth of shares (633 units at $4.23), decreasing direct ownership by 7% to 8,669 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 755d
  Chief R&D Officer Valamehr Bahram was granted 200,000 shares, increasing direct ownership by 127% to 358,069 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 755d
  SEC Form 4 filed by Director Mozaffarian Neelufar

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 755d
  General Counsel and Secretary Tahl Cindy was granted 200,000 shares, increasing direct ownership by 140% to 342,361 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Lee Michael Stewart

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Rastetter William H

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Jooss Karin

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Coughlin Timothy

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Agarwal Shefali

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Xu Yuan

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Epstein Robert S

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Director Mendlein John

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 883d
  SEC Form 4 filed by Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 935d
  SEC Form 4 filed by Wolchko J Scott

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 935d
  SEC Form 4 filed by Tahl Cindy

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 935d
  SEC Form 4 filed by Dulac Edward J Iii

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)

Other FATE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends